IIUM Repository

Dr Nik Arsyad Nik Muhamad Affendi

Assistant Professor

Internal Medicine

IIUM

Internal medicine

Profile Picture

Latest Additions

  1. Nik Muhamad Affendi, Nik Arsyad and Hilmi, Ida Normiha (2024) Endoscopy for Crohn’s disease-related strictures: can we finally replace the surgeons? Journal of Gastroenterology and Hepatology, 39 (5). pp. 779-780. ISSN 0815-9319 E-ISSN 1440-1746
  2. Xin Hui, Khoo and Nik Muhamad Affendi, Nik Arsyad and Leow, Alex Hwong Ruey and Hilmi, Ida Normiha (2023) Long term efficacy and persistence of biologics therapy in Crohn’s disease in multiracial Asian country. Journal of Gastroenterology and Hepatology, 38 (S3). p. 271. ISSN 0815-9319 E-ISSN 1440-1746
  3. Ban Hong, Ang and Nik Muhamad Affendi, Nik Arsyad and Hilmi, Ida Normiha (2023) Upadacitinib as rescue therapy in acute severe ulcerative colitis: a Malaysia tertiary center experience. Journal of Gastroenterology and Hepatology, 38 (S3). p. 263. ISSN 0815-9319 E-ISSN 1440-1746
  4. Nik Muhamad Affendi, Nik Arsyad and Ismail, Farhana and Jaafar, Khairul Azhar and Md Jalil, Muhammad Ateeq and Wan Abdul Jalil, Wan Hasrol Faes (2018) Retrospective study on upper gastrointestinal endoscopic findings in patients with Dyspepsia without Alarm Features in International Islamic University Malaysia Medical Centre. IIUM Medical Journal Malaysia, 17 Supplementary (1). p. 84. ISSN 1823-4631 E-ISSN 2735-2285
  5. Hashim, Mohd Badrul Hisyam and Nik Muhamad Affendi, Nik Arsyad and Ho, Shiaw Hooi (2023) Factors associate with high adenoma detection rate: a tertiary centre experience. In: GUT 2023, Kuala Lumpur.
  6. Nik Muhamad Affendi, Nik Arsyad and Xin Hui, Khoo and leow, alex hwong ruey and hilmi, ida normiha (2023) Long term efficacy and persistence of Biologics Therapy in Crohn Disease in Multiracial Asian Country: A real world experience. In: GUT 2023, Kuala Lumpur.
  7. CK, vikneshwaran and skantha, ruben and Shahrani, Shahreedhan and Nik Muhamad Affendi, Nik Arsyad and jayaraman, thevaraajan and Chuah, Kee Huat and Stanley, khoo and Rajaram, Ruveena Bhavani and Mahadeva, Sanjiv (2023) Hepatic Hydrothorax: single centre’s experience in Malaysia on the utility of Octreotide - A case series. In: GUT 2023, 22-23 August 2023, Kuala Lumpur.
  8. Nik Muhamad Affendi, Nik Arsyad and Ho, Shiaw Hooi and Lau, Peng Choong and Mahadeva, Sanjiv (2023) An unusual case of achalasia cardia mimic: why cant I cut it trough? In: GUT 2023, 22th August 2023, Kuala Lumpur.
  9. hilmi, ida normiha and Nik Muhamad Affendi, Nik Arsyad and Shahrani, Shahreedhan and Mohamed Talha, Abdul Malik and Leow, alex hwong-ruey and Xin Hui, Khoo (2023) High accuracy of a simplified, practical algorithm in a differentiating Crohn’s disease from Intestinal Tuberculosis. Digestive disease, 41 (4). pp. 581-588. ISSN 0257-2753 E-ISSN 1421-9875
  10. Wong, Wei Jin and Nik Muhamad Affendi, Nik Arsyad and Liau, Siow Yen and Mahendran, Hans Alexander and Peng Choong, Lau and Ho, Shiaw Hooi and Mahadeva, Sanjiv (2023) When is POEM truly equivalent to LHM? A comparison of complication rates during the learning curve. Surgical Endoscopy, 37. pp. 1735-1741. ISSN 0930-2794 E-ISSN 1432-2218
  11. Shahrani, Shahreedhan and Singh Gill, Sandeep and Sooi, Choong Yeong and Skantha, Ruben and Chandra Kumar, C. Vikneshwaran and Limun, Mohd Fairul and Nik Muhamad Affendi, Nik Arsyad and Chuah, Kee Huat and Khoo, Stanley and Rajaram, Ruveena Bhavani and Chan, Wah Keong and Mahadeva, Sanjiv (2023) Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease. Journal of Gastroenterology and Hepatology, 38 (10). pp. 1818-1822. ISSN 0815-9319 E-ISSN 1440-1746
  12. Nik Muhamad Affendi, Nik Arsyad and Ooi, Chong Jin and Hilmi, Ida Normiha (2022) Accelerated ustekinumab dosing as rescue therapy in acute severe ulcerative colitis. Journal of Gastrointestinal and Liver Diseases, 31 (4). pp. 478-479. ISSN 1841-8724 E-ISSN 1842-1121
  13. Nik Muhamad Affendi, Nik Arsyad and Ooi, Choon Jin and Hilmi, Ida Normiha (2023) Reply - Accelerated dose of ustekinumab for acute severe ulcerative colitis. Journal of Gastrointestinal and Liver Diseases, 32 (3). p. 412. ISSN 1841-8724 E-ISSN 1842-1121
  14. Shahrani, Shahreedhan and balakrishnan, Preetica mayuri and ravi, Koshni and singh, sandeep and chee, sher wye and zulkeflie, saiful hasyim and ng, ying zhuang and lee, wai kin and AK, Mohamed amin and Sooi, Choong Yeong and CK, vikneshwaran and Nik Muhamad Affendi, Nik Arsyad and skantha, ruben and Limun, Mohd Fairul and Wan ibrahim, Nik Razima and Mohamed Talha, Abdul Malik and Chuah, Kee Huat and Stanley, khoo and Rajaram, Ruveena Bhavani and chan, wah keong and Mahadeva, Sanjiv and UNSPECIFIED and UNSPECIFIED and UNSPECIFIED (2022) Frequency of significant steatosis in various chronic liver diseases: an evaluation with Transient Elastography (TE). In: GUT 2022, 19 - 21 August 2022, kuala Lumpur convention centre. (Unpublished)
  15. shahrani, shahreedhan and balakrishnan, preetica mayuri and ravi, koshni and singh, sandeep and chee, sher wye and zulkeflie, saiful hasyim and zhuang, ng ying and lee, wai kin and amin, Mohamed and sooi, choong yeong and CK, vikneshwaran and Nik Muhamad Affendi, Nik Arsyad and skantha, ruben and Limun, Mohd Fairul and mohamed talha, abdul malik and Chuah, Kee Huat and stanley, khoo and Rajaram, Ruveena Bhavani and chan, wah keong and Mahadeva, Sanjiv and UNSPECIFIED and UNSPECIFIED (2022) Frequency of significant fibrosis in various chronic liver diseases: an evaluation with Transient Elastography (TE). In: GUT 2022, 19 - 21 August 2022, Kuala Lumpur Convention Centre. (Unpublished)
  16. Fairul, Mohd and Nik Muhamad Affendi, Nik Arsyad and Shahrani, Shahreedhan and Xin Hui, Khoo and hilmi, ida normiha (2022) Impact of early versus late use of biologic therapy on cumulative surgical rates in patients with IBD. In: GUT 2022, 19 - 21 August 2022, Kuala Lumpur Convention Centre. (Unpublished)
  17. Nik Muhamad Affendi, Nik Arsyad and Xin Hui, Khoo and hilmi, ida normiha (2022) Efficacy, safety and persistence of Ustekinumab versus Infliximab in bionaive patients with moderate to severe Crohn disease patients: a real world experience. In: GUT 2022, 19 - 21 August 2022, Kuala Lumpur Convention Centre. (Unpublished)
  18. wong, wei jin and Nik Muhamad Affendi, Nik Arsyad and siow, sze li and mahendran, han alexander and Lau, Peng Choong and Ho, Shiaw Hooi and Mahadeva, Sanjiv (2022) When is poem truly equivalent to LHM? A comparison of complication rates during the learning curve. In: GUT 2022, 19 - 21 August 2022, Kuala Lumpur Convention Centre. (Unpublished)
  19. Nik Muhamad Affendi, Nik Arsyad and Choon, Jin Ooi and hilmi, ida normiha (2022) Accelerated dose of Ustekinumab as rescue therapy in acute severe ulcerative colitis. In: GUT 2022, 19 - 21 August 2022, Kuala Lumpur |Convention ||Centre. (Unpublished)
  20. Nik Muhamad Affendi, Nik Arsyad and Xin Hui, Khoo and Chuah, Kee Huat and Hilmi, ida normiha (2022) Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease. In: GUT 2022, kuala Lumpur convention centre. (Unpublished)

Most Viewed Items

Item titleViews
1Acquiring new complex endoscopic skills: experience from the development of peroral endoscopic myotomy (POEM) in Malaysia600
2Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease553
3Efficacy and safety of per-oral endoscopic myotomy for the treatment of Achalasia Cardia in Malaysia: a single centre study548
4Efficacy, safety and persistence of Ustekinumab versus Infliximab in bionaive patients with moderate to severe Crohn disease patients: a real world experience445
5Changing landscape of liver cirrhosis in multi-racial Asian country: a decade comparison435
6Biologic exposure of short duration results in a marked reduction in cumulative surgical rates in Malaysian patients with inflammatory bowel disease375
7Frequency of significant fibrosis in various chronic liver diseases: an evaluation with Transient Elastography (TE)357
8Impact of early versus late use of biologic therapy on cumulative surgical rates in patients with IBD357
9Accelerated dose of Ustekinumab as rescue therapy in acute severe ulcerative colitis349
10When is poem truly equivalent to LHM? A comparison of complication rates during the learning curve348
11Frequency of significant steatosis in various chronic liver diseases: an evaluation with Transient Elastography (TE)347
12Changing landscape of liver cirrhosis in multi-racial Asian country: a decade comparison340
13Efficacy and safety of per-oral endoscopic myotomy for the treatment of achalasia cardia in Malaysia: a single centre study324
14Accelerated ustekinumab dosing as rescue therapy in acute severe ulcerative colitis158
15When is POEM truly equivalent to LHM? A comparison of complication rates during the learning curve156
16Reply - Accelerated dose of ustekinumab for acute severe ulcerative colitis149
17Retrospective study on upper gastrointestinal endoscopic findings in patients with Dyspepsia without Alarm Features in International Islamic University Malaysia Medical Centre143
18Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease141
19Long term efficacy and persistence of biologics therapy in Crohn’s disease in multiracial Asian country141
20High accuracy of a simplified, practical algorithm in a differentiating Crohn’s disease from Intestinal Tuberculosis134
21Upadacitinib as rescue therapy in acute severe ulcerative colitis: a Malaysia tertiary center experience132
22Long term efficacy and persistence of Biologics Therapy in Crohn Disease in Multiracial Asian Country: A real world experience73
23Factors associate with high adenoma detection rate: a tertiary centre experience64
24Hepatic Hydrothorax: single centre’s experience in Malaysia on the utility of Octreotide - A case series61
25An unusual case of achalasia cardia mimic: why cant I cut it trough?60
26Endoscopy for Crohn’s disease-related strictures: can we finally replace the surgeons?3